Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) have become hotspot of tumor markers for small cell lung cancer (SCLC), and the aim of this study is to evaluate and compare the diagnostic value of serum ProGRP and NSE in SCLC by meta-analysis. Here, ENO2 is linked to small cell lung carcinoma.